diclofenac has been researched along with Dry Eye in 9 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "1% diclofenac sodium for 1 month for his dry eye." | 7.78 | Late corneal perforation with topical diclofenac sodium use after radiotherapy. ( Demirel, S; Sarac, O, 2012) |
| "Treatment with diclofenac sodium, 0." | 6.69 | Diclofenac sodium, 0.1% (Voltaren Ophtha), versus sodium chloride, 5%, in the treatment of filamentary keratitis. ( Appel, I; Avisar, R; Robinson, A; Weinberger, D; Yassur, Y, 2000) |
| "In the current study, we used 56 female BALB/c mice with induced dry eye syndrome to evaluate the therapeutic effects of formal saline (FS), sodium hyaluronate (SH), diclofenac sodium (DS), olopatadine (OP), retinoic acid (RA), fluoromethanole (FML), cyclosporine A (CsA), and doxycycline hyclate (DH)." | 3.83 | Efficacy of Several Therapeutic Agents in a Murine Model of Dry Eye Syndrome. ( Kilic, S; Kulualp, K, 2016) |
| "1% diclofenac sodium for 1 month for his dry eye." | 3.78 | Late corneal perforation with topical diclofenac sodium use after radiotherapy. ( Demirel, S; Sarac, O, 2012) |
| "Forty healthy volunteers instilled Dicloabak in the randomised eye and thiomersal-preserved diclofenac in the other eye, according to a strictly identical dosing regimen, for 28 days." | 2.71 | [Ocular tolerance of a new formulation of nonpreserved diclofenac]. ( Chiambaretta, F; Creuzot-Garcher, C; Dubray, C; Pilon, F; Pouliquen, P; Rebika, H; Rigal, D, 2004) |
| "Treatment with diclofenac sodium, 0." | 2.69 | Diclofenac sodium, 0.1% (Voltaren Ophtha), versus sodium chloride, 5%, in the treatment of filamentary keratitis. ( Appel, I; Avisar, R; Robinson, A; Weinberger, D; Yassur, Y, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sawazaki, R | 1 |
| Ishihara, T | 1 |
| Usui, S | 1 |
| Hayashi, E | 1 |
| Tahara, K | 1 |
| Hoshino, T | 1 |
| Higuchi, A | 1 |
| Nakamura, S | 1 |
| Tsubota, K | 1 |
| Mizushima, T | 1 |
| Kilic, S | 1 |
| Kulualp, K | 1 |
| Demirel, S | 1 |
| Sarac, O | 1 |
| Aragona, P | 1 |
| Stilo, A | 1 |
| Ferreri, F | 1 |
| Mobrici, M | 1 |
| Chiambaretta, F | 1 |
| Creuzot-Garcher, C | 1 |
| Pilon, F | 1 |
| Pouliquen, P | 1 |
| Rebika, H | 1 |
| Dubray, C | 1 |
| Rigal, D | 1 |
| Quintana-Hau, JD | 1 |
| Cruz-Olmos, E | 1 |
| López-Sánchez, MI | 1 |
| Sánchez-Castellanos, V | 1 |
| Baiza-Durán, L | 1 |
| González, JR | 1 |
| Mondragón-Flores, R | 1 |
| Hernández-Santoyo, A | 1 |
| Reid, AL | 1 |
| Henderson, R | 1 |
| Sharir, M | 1 |
| Avisar, R | 1 |
| Robinson, A | 1 |
| Appel, I | 1 |
| Yassur, Y | 1 |
| Weinberger, D | 1 |
4 trials available for diclofenac and Dry Eye
| Article | Year |
|---|---|
Effects of the topical treatment with NSAIDs on corneal sensitivity and ocular surface of Sjögren's syndrome patients.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cornea; Diclofenac; Dry Eye Syndromes; Epithel | 2005 |
[Ocular tolerance of a new formulation of nonpreserved diclofenac].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Administration Schedule; Dry Eye Sy | 2004 |
Characterization of the novel ophthalmic drug carrier Sophisen in two of its derivatives: 3A Ofteno and Modusik-A Ofteno.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chromatography, High Pressure Liquid; Cyclosporine | 2005 |
Diclofenac sodium, 0.1% (Voltaren Ophtha), versus sodium chloride, 5%, in the treatment of filamentary keratitis.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cornea; Diclofenac; Dry Eye Syndromes; Female; Humans | 2000 |
5 other studies available for diclofenac and Dry Eye
| Article | Year |
|---|---|
Diclofenac protects cultured human corneal epithelial cells against hyperosmolarity and ameliorates corneal surface damage in a rat model of dry eye.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Diclofenac; Disease Models, Anima | 2014 |
Efficacy of Several Therapeutic Agents in a Murine Model of Dry Eye Syndrome.
Topics: Animals; Anti-Inflammatory Agents; Blinking; Cyclosporine; Diclofenac; Disease Models, Animal; Dry E | 2016 |
Late corneal perforation with topical diclofenac sodium use after radiotherapy.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents, Non-Steroidal; Carcinoma; Corneal Perforat | 2012 |
Diclofenac and dry, irritable eyes.
Topics: Diclofenac; Dry Eye Syndromes; Female; Humans; Middle Aged | 1994 |
Exacerbation of asthma by topical diclofenac.
Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Diclofenac; Dry Eye Syndro | 1997 |